Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC   US23254L3069

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/15/2014 09/16/2014 09/17/2014 09/18/2014 09/19/2014 Date
3.09(c) 3.1(c) 3.12(c) 3.15(c) 3.1199 Last
101 891 62 562 19 431 45 706 46 201 Volume
-1.28% +0.32% +0.65% +0.96% -0.96% Change
More quotes
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company.It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
Surperformance© rating of Cyclacel Pharmaceuticals I
Trading Rating : Investor Rating :
More about the company
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 0,88 M
EBIT 2014 -24,2 M
Net income 2014 -22,3 M
Debt 2014 -
Yield 2014 -
Sales 2015 0,25 M
EBIT 2015 -29,2 M
Net income 2015 -27,5 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 80,8x
Capi. / Sales 2015 286x
Capitalization 71,4 M
More Financials
Latest news on CYCLACEL PHARMACEUTICALS I
8h ago CYCLACEL PHARMACEUTICALS : to Present at BioCentury's Newsmakers in the Biotech ..
1d ago CYCLACEL PHARMACEUTICALS : CYC065 CDK Inhibitor Demonstrates Therapeutic Potenti..
09/11 CYCLACEL PHARMACEUTICALS : Change in Directors or Principal Officers, Other Even..
09/11 CYCLACEL PHARMACEUTICALS : Appoints Samuel L. Barker, Ph.D., to Board of Directo..
09/10 CYCLACEL PHARMACEUTICALS : Announces Abstract Selected for Presentation at Socie..
09/02 CYCLACEL PHARMACEUTICALS : to Present at 16th Rodman & Renshaw Annual Global Inv..
08/12 CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
08/12 CYCLACEL PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
08/12 Cyclacel Pharmaceuticals Reports Second Quarter 2014 Financial Results
08/06 CYCLACEL PHARMACEUTICALS : to Release 2014 Second Quarter Financial Results
06/17 CYCLACEL PHARMACEUTICALS : to Present at 9th Annual JMP Securities Healthcare Co..
05/31 CYCLACEL PHARMACEUTICALS : Provides Update on Its Clinical Development Plan of S..
More news
Comments 
Advertisement
Income Statement Evolution
Cyclacel Pharmaceuticals I : Income Statement Evolution
More Financials
EPS Revisions
Cyclacel Pharmaceuticals I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF